Edge Wealth Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,144	Closed	-$251K	–	536
2020 Q2	$251K	Sell	9,144 -20	-0.2%	-$658	0.05%	126
2020 Q1	$271K	Buy	9,164 +50	+0.5%	+$1.32K	0.06%	123
2019 Q4	$252K	Buy	9,114 +700	+8%	+$15.9K	0.05%	134
2019 Q3	$153K	Hold	8,414	–	–	0.04%	154
2019 Q2	$207K	Buy	8,414 +1,414	+20%	+$21.3K	0.05%	139
2019 Q1	$67K	Buy	7,000 +500	+8%	+$4.86K	0.02%	216
2018 Q4	$58K	Sell	6,500 -200	-3%	-$1.93K	0.02%	234
2018 Q3	$75K	Sell	6,700 -1,750	-21%	-$24.8K	0.02%	222
2018 Q2	$108K	Sell	8,450 -1,375	-14%	-$20.1K	0.03%	185
2018 Q1	$166K	Sell	9,825 -8,488	-46%	-$129K	0.04%	134
2017 Q4	$145K	Sell	18,313 -1,000	-5%	-$8.03K	0.04%	146
2017 Q3	$150K	Buy	+19,313	New	+$122K	0.05%	141
2017 Q2	–	Sell	-1,500	Closed	-$11K	–	553
2017 Q1	$11K	Buy	1,500 +500	+50%	+$3.67K	﹤0.01%	341
2016 Q4	$7K	Buy	+1,000	New	+$6.88K	﹤0.01%	370
2016 Q1	–	Sell	-3,800	Closed	-$29K	–	479
2015 Q4	$29K	Sell	3,800 -8,500	-69%	-$59K	0.01%	220
2015 Q3	$71K	Sell	12,300 -1,200	-9%	-$9.35K	0.03%	159
2015 Q2	$123K	Buy	13,500 +4,500	+50%	+$50.2K	0.04%	129
2015 Q1	$108K	Buy	+9,000	New	+$101K	0.04%	130